COVID-19 Research
SASH continues to be part of the national effort to improve prevention, diagnosis and treatment of the coronavirus through research.
Our staff and patients have supported over 16 COVID-19 research projects since March 2020.
We are very grateful to everyone that has played a part in contributing to these studies!
You can read more about some of the studies that SASH has supported here:
The RECOVERY Trial
This study, run by the University of Oxford, aims to compare several different treatments that may be useful for patients with COVID-19 and/or influenza pneumonia. The study has already found four treatments that are effective for severe COVID-19.
At SASH, we have contributed to the study by being able to offer our patients hospitalised with COVID-19 the study treatments and by including 329 patients.
More details are available here at: https://www.recoverytrial.net/
ISARIC CCP (Clinical Characterisation Protocol for Severe Emerging Infections in the UK)
At SASH we contribute important data to the CCP UK study which collects information about infectious diseases and potential exposures of public health importance in response to potential public health crises – the study was activated in January 2020 in response to the emergence of COVID-19.
Read more about how the CCP UK study uses data; CCP UK Patient Data Notification
SIREN (SARS-CoV2 immunity and reinfection evaluation)
SIREN was initiated by the UK Health and Security Agency at 135 NHS sites in response to the COVID-19 pandemic. It has provided vital research into immunity and vaccine effectiveness. The study includes healthcare workers who undertake regular testing for COVID-19 infection and vaccine immunity.
Our SASH staff came together quickly to provide data for 255 participants and continues to contribute to the current Winter Pressures sub-study.